Anti-Redness Clinical Study

ChinaNorm

Status

Completed

Conditions

Redness

Treatments

Other: Facial serum application

Other: Forearm serum application

Study type

Interventional

Funder types

Industry

Identifiers

NCT07200492

C23036010

Details and patient eligibility

About

This clinical study is a single-center, randomized, split-face, on-site controlled trial conducted at Shanghai China-Norm Quality Technical Service Co., Ltd. The primary objective is to evaluate the efficacy of Eucerin Ultrasensitive Repair Intensive Source Serum in providing instant and long-lasting (24-hour) soothing and repairing effects under induced redness conditions. The design involves recruiting 30 healthy Chinese female subjects aged 18-60 years, who meet stringent inclusion/exclusion criteria, including absence of skin conditions and no recent participation in similar studies. Redness is induced using 50% Glycolic Acid on the entire face and tape stripping on both forearms.

Enrollment

32 patients

Sex

Female

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Chinese female whose age range from 18 to 60 years old;
Be in general good health and good mental state;
Have no any broken,scars,birthmarks and other imperfections on the test area;
Redness/erythema≥grade 2 after modelling inducing and the score of redness must be increased after inducing;
Not currently be participating in any other study involving the test area(Face and Forearm);
Not have participated in any other study involving the test area in the past one month;
Be willing to read,understand and able to sign the Informed Consent Form and Photo Release From;
Be willing to comply with all study protocol requirements.

Exclusion criteria

Intending to get pregnant, be pregnant, be lactating, be within 6 months of delivery or be unwilling to take necessary precautions to avoid a pregnancy;
Having used antihistamine drugs in the past 1 week or immunosuppressants in the past 1 month;
Taken anti-allergic drug/injections in the past 1 month;
Presently have allergies, allergic dermatitis or skin disease;
Have sensitivity or even allergy to topical products, ingredients or fragranced products;
Have history of allergies;
Have history of suffering from skin diseases (such as psoriasis, eczema, skin cancer, etc.);
Have used any anti-inflammatory treatment on the test area within 2 months prior to this study starting date;
Has a chronic medical condition that may interfere with testing (e.g., asthma, insulin-dependent diabetes, lupus, rheumatoid arthritis or other immune/auto-immune diseases);
Have used any scrubs or peeling product (regardless of method) or self-tanning products or oil control products in the past 3 days;
Have received cosmetic medical procedures on the face (such as injectable anti-wrinkle products, cosmetic surgery, tattoo removal, home light facial procedures or home use medical devices, etc.) in the past 1 month;
Have excessive sun exposure or ultraviolet light exposure in the past 1 month;
Have applied ortho-hydroxybenzoic acid, hydroquinone in the past 3 months; or used prescriptions (such as antibiotic, retinoids, alpha hydroxyl acid and steroid), oral contraceptives；
Avoid providing emergency contact;
Subjects that are not compliant with the selection criteria or not proper for participation as determined by Principal Investigator;
An employee of the cosmetic companies or Shanghai China-Norm Quality technical service Co., Ltd.